Cash Flow Statement

Growth Metrics

Assets (QoQ)Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Capital Expenditures (QoQ)Cash & Equivalents (QoQ)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)Cash from Investing Activities (QoQ)Cash from Operations (QoQ)Cash from Operations Growth (1y)Cash from Operations Growth (3y)Cash from Operations Growth (5y)EBIT (QoQ)EBIT Growth (1y)EBIT Growth (3y)EBIT Growth (5y)EBIT Margin (QoQ)EBIT Margin Growth (1y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBT (QoQ)EBT Growth (1y)EBT Growth (3y)EBT Growth (5y)EBT Margin (QoQ)EBT Margin Growth (1y)EPS (Basic) (QoQ)EPS (Basic) Growth (1y)EPS (Basic) Growth (3y)EPS (Basic) Growth (5y)EPS (Weighted Average and Diluted) (QoQ)EPS (Weighted Average and Diluted) Growth (1y)EPS (Weighted Average and Diluted) Growth (3y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin (QoQ)FCF Margin Growth (1y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Free Cash Flow Growth (3y)Free Cash Flow Growth (5y)Gross Margin (QoQ)Gross Margin Growth (1y)Gross Profit (QoQ)Gross Profit Growth (1y)Interest Coverage Ratio (QoQ)Interest Coverage Ratio Growth (1y)Interest Coverage Ratio Growth (3y)Interest Coverage Ratio Growth (5y)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Net Cash Flow Growth (3y)Net Cash Flow Growth (5y)Net Income (QoQ)Net Income Growth (1y)Net Income Growth (3y)Net Income Growth (5y)Net Income towards Common Stockholders (QoQ)Net Income towards Common Stockholders Growth (1y)Net Income towards Common Stockholders Growth (3y)Net Income towards Common Stockholders Growth (5y)Net Margin (QoQ)Net Margin Growth (1y)Operating Income (QoQ)Operating Income Growth (1y)Operating Income Growth (3y)Operating Income Growth (5y)Operating Margin (QoQ)Operating Margin Growth (1y)Profit After Tax (QoQ)Profit After Tax Growth (1y)Profit After Tax Growth (3y)Profit After Tax Growth (5y)Return on Assets (QoQ)Return on Assets Growth (1y)Return on Assets Growth (3y)Return on Assets Growth (5y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Capital Employed Growth (5y)Return on Equity (QoQ)Return on Equity Growth (1y)Return on Equity Growth (3y)Return on Equity Growth (5y)Return on Sales (QoQ)Return on Sales Growth (1y)Revenue (QoQ)Revenue Growth (1y)Share-based Compensation (QoQ)Share-based Compensation Growth (1y)Share-based Compensation Growth (5y)Shareholder's Equity (QoQ)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Tax Rate (QoQ)Total Debt (QoQ)Total Debt Growth (1y)Total Debt Growth (3y)Total Debt Growth (5y)

Others

Regenerex Pharma (RGPX) Free Cash Flow Growth (1y) (2012 - 2025)

Historic Data

Download Data 🔒

Date	Value
Sep 30, 2025	-310.21%
Jun 30, 2025	-763.77%
Mar 31, 2025	-1,893.79%
Dec 31, 2024	-58.99%
Sep 30, 2024	27.54%
Jun 30, 2024	55.69%
Mar 31, 2024	-2,030.79%
Dec 31, 2023	-248.70%
Sep 30, 2023	-1,750.05%
Jun 30, 2023	-256.07%
Mar 31, 2023	-122.03%
Dec 31, 2022	-39.02%
Sep 30, 2022	66.56%
Jun 30, 2022	-103.67%
Dec 31, 2021	-23.13%
Sep 30, 2021	-141.30%
Jun 30, 2021	-88.69%
Dec 31, 2020	-125.26%
Sep 30, 2020	-108.54%
Jun 30, 2020	-151.54%
Mar 31, 2020	-2,275.98%
Dec 31, 2019	195.59%
Sep 30, 2019	63,939.72%
Jun 30, 2019	1,845.71%
Mar 31, 2019	183.87%
Dec 31, 2018	194.68%
Sep 30, 2018	-93.16%
Jun 30, 2018	-17.50%
Mar 31, 2018	2,352.96%
Nov 30, 2014	-282.11%
Aug 31, 2014	79.45%
May 31, 2014	-31.85%
Feb 28, 2014	-209.63%
Nov 30, 2013	-21.68%
Aug 31, 2013	29.21%
May 31, 2013	-171.08%
Feb 28, 2013	79.34%
Aug 31, 2012	7.54%